If your insurance won't cover GLP-1 medications — or you don't have insurance at all — you're not alone. Millions of Americans want access to semaglutide, tirzepatide, or orforglipron but face retail prices that can exceed $1,300/month. The good news: the self-pay landscape has changed dramatically in 2026. Multiple options now exist at prices that were unthinkable two years ago.
Here's every FDA-approved GLP-1 option ranked by what you'll actually pay out of pocket, with no insurance involved.
Every GLP-1 Ranked by Self-Pay Cost
1. Foundayo (Orforglipron) — Starting at $149/month
The cheapest branded GLP-1 available in 2026.
Foundayo through LillyDirect offers the lowest entry point in the branded GLP-1 market:
- Starting dose (0.8 mg): $149/month
- Mid-range doses (2.5–5.5 mg): $199–$249/month
- Maintenance doses (9–17.2 mg): $299–$349/month
- Daily oral pill — no injections, no cold storage
- No fasting requirements
- Weight loss: approximately 12.4% of body weight in completers
For self-pay patients, Foundayo is the clear value leader. The oral format also eliminates the cost of needles and sharps disposal. See our Foundayo savings card guide for additional ways to reduce costs.
2. Oral Wegovy (Semaglutide Tablets) — Starting at $149/month
The pill version of the most proven GLP-1 for weight loss.
Oral Wegovy matches Foundayo's starting price for lower doses:
- Lower doses: approximately $149/month
- Higher doses: $199–$299/month
- Requires 30 minutes of fasting after taking on an empty stomach
- Weight loss: approximately 16.6% in completers (OASIS 4 data)
- Semaglutide has the strongest long-term cardiovascular data (SELECT trial)
If you're willing to manage the fasting requirements, oral Wegovy may deliver more weight loss per dollar. The trade-off is daily dosing convenience versus Foundayo's take-anytime flexibility.
3. Zepbound (Tirzepatide) — $299–$549/month via LillyDirect
The most potent GLP-1 for weight loss, now at reduced self-pay prices.
- Starting dose (2.5 mg): $299/month via LillyDirect
- Maintenance doses (10–15 mg): $399–$549/month
- Weekly injection (not daily)
- Dual GIP/GLP-1 mechanism
- Weight loss: approximately 22.5% in completers — the strongest of any available GLP-1
Zepbound is more expensive than oral options but delivers the most dramatic weight loss results. For patients who can afford $399+/month, it remains the most effective single medication for obesity.
4. Ozempic (Semaglutide Injection) — $936/month retail
Still the most widely prescribed GLP-1, but expensive without insurance.
- Retail price: approximately $936/month
- GoodRx best price: $800–$850/month at select pharmacies
- Weekly injection
- Technically approved for diabetes, not weight loss (though widely used off-label)
- Weight loss: approximately 15% in trials
At nearly $1,000/month self-pay, Ozempic is hard to justify for uninsured patients when cheaper alternatives exist. The Novo Nordisk savings card only works for commercially insured patients.
5. Wegovy (Semaglutide Injection) — $1,349/month retail
The gold-standard FDA-approved weight loss injection, but the most expensive branded option.
- Retail price: approximately $1,349/month
- Self-pay via Ro: $449–$600/month (discounted but still premium)
- Weekly injection
- FDA-approved specifically for weight management
- Strongest cardiovascular evidence (SELECT trial)
Injectable Wegovy remains excellent medically but is nearly impossible to afford without insurance or significant discounts. Oral Wegovy offers similar efficacy at a fraction of the price.
6. Saxenda (Liraglutide) — $1,349/month retail
An older GLP-1 that's now outclassed on both efficacy and cost.
- Retail price: approximately $1,349/month
- Daily injection (not weekly)
- Weight loss: approximately 5–8% — significantly less than newer options
- First-generation GLP-1 for weight loss
Saxenda is hard to recommend for self-pay patients in 2026. It costs as much as Wegovy but delivers roughly half the weight loss. Newer medications have made it largely obsolete for cash-pay patients.
Complete Self-Pay Cost Comparison
| Medication | Best Self-Pay Price | Type | Frequency | Weight Loss |
|---|---|---|---|---|
| Foundayo | $149–$349/mo | Oral pill | Daily | ~12.4% |
| Oral Wegovy | $149–$299/mo | Oral pill | Daily | ~16.6% |
| Zepbound | $299–$549/mo | Injection | Weekly | ~22.5% |
| Ozempic | $800–$936/mo | Injection | Weekly | ~15% |
| Wegovy (inj.) | $449–$1,349/mo | Injection | Weekly | ~15–17% |
| Saxenda | $1,200–$1,349/mo | Injection | Daily | ~5–8% |
Manufacturer Savings Programs
Several manufacturers offer savings programs, but they generally require commercial insurance:
- Lilly (Foundayo, Zepbound): Savings card reduces copay to $25/mo for commercially insured. LillyDirect provides the best self-pay pricing regardless of insurance status.
- Novo Nordisk (Ozempic, Wegovy): Savings cards for commercially insured patients only. No equivalent to LillyDirect for self-pay.
- Patient Assistance Programs: Both Lilly and Novo Nordisk offer PAPs for low-income patients. Income requirements typically ≤400% of Federal Poverty Level.
A Warning About Compounded GLP-1s
If you're tempted by cheap compounded semaglutide or tirzepatide online, be extremely cautious:
- FDA enforcement is increasing — many compounding pharmacies have been shut down in 2025–2026
- Quality is unverified — compounded medications don't undergo the same testing as branded versions
- Dosing may be inaccurate — under-dosing means wasted money; over-dosing means dangerous side effects
- Legal risk is real — purchasing from illegitimate sources could have legal consequences
With branded options starting at $149/month, the risk-reward calculation for compounded medications has fundamentally changed. See our guide to compounded semaglutide alternatives for more details.
Our Recommendation for Self-Pay Patients
For most uninsured patients in 2026, start with Foundayo at $149/month. It offers the best combination of affordability, convenience (oral, no fasting), and meaningful weight loss. If you want maximum weight loss and can afford $300+/month, Zepbound delivers the strongest results. Oral Wegovy sits in between — similar pricing to Foundayo but with stricter dosing requirements and potentially stronger efficacy.
Don't pay $900+/month for Ozempic or $1,300+/month for injectable Wegovy when cheaper, equally effective (or more convenient) options exist. The GLP-1 market has matured, and self-pay patients finally have real choices.
Sources
- Eli Lilly and Company. LillyDirect Pricing for Foundayo and Zepbound. April 2026.
- Novo Nordisk. Oral Wegovy and Injectable Wegovy Pricing Information. 2026.
- GoodRx. GLP-1 Medication Price Comparison. Accessed April 2026.
- FDA. "Information on Compounded GLP-1 Products." Updated March 2026.
- ATTAIN-1, OASIS 4, SURMOUNT-1 Clinical Trials. Weight loss efficacy data.